|
시장보고서
상품코드
2050918
POC 진단 시장 : 기술별, 용도별, 최종사용자별, 지역별Point of Care Diagnostics Market, By Technology, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
POC 진단 시장은 2026년에 51억 3,000만 달러로 추정되며, 2033년까지 80억 2,000만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 6.6%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 51억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.60% | 2033년 시장 규모 예측 : | 820억 달러 |
현장진단(POC, Point of Care)이란 검사실 밖에서 환자의 진료가 이루어지는 현장 근처 또는 그 장소에서 시행되는 의료 진단 검사를 말합니다. 기존에는 대부분의 진단 검사가 중앙 집중식 검사실에서 이루어졌습니다. 그러나 POC 진단은 검체를 멀리 떨어진 검사실로 운반하지 않고도 보다 빠른 결과 제공, 신속한 임상적 판단, 즉각적인 치료가 가능합니다. 기술의 발전으로 진료소, 응급실, 약국, 가정 등 환자와 밀접한 환경에 적합한 휴대가 간편하고 사용하기 쉬운 기기 개발이 가능해졌습니다. 신속한 검사 및 분산형 의료에 대한 수요 증가, 감염성 질환 발생률 증가, 만성질환에 취약한 고령 인구 증가는 세계 현장진단 시장의 성장을 견인할 것으로 보입니다.
시장 역학
세계 현장진단 시장의 성장은 신속하고 편리한 실시간 검사 결과에 대한 수요 증가, 만성질환 및 감염성 질환의 유병률 증가, 전 세계 고령화 추세, 사용자 친화적이고 휴대 가능한 현장진단 기기 개발로 이어지는 기술 발전 등의 요인에 의해 주도되고 있습니다. 기술 발전이 주도하고 있습니다. 그러나 개발도상국의 인프라 및 숙련된 전문가 부족, 고급 POC 장비의 높은 비용, 일부 장비에 따른 신뢰할 수 없는 검사 결과 등은 시장 성장을 저해할 수 있습니다. 또한, 신흥 시장의 미개척 기회, AI 및 IoT와 같은 첨단 기술과 POC 기기의 통합, 재택치료에서의 POC 검사 적용 확대는 시장 관계자들에게 큰 비즈니스 기회를 제공할 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 저해요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들이 채택하고 있는 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 POC(Point of Care) 진단 시장의 주요 기업 프로파일을 작성했습니다. 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 POC(Point of Care) 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 POC(Point of Care) 진단 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 POC 진단 시장 : 기술별, 2021년-2033년
제5장 세계의 POC 진단 시장 : 용도별, 2021년-2033년
제6장 세계의 POC 진단 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 POC 진단 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
LSH 26.06.15Point Of Care Diagnostics Market is estimated to be valued at USD 5.13 Bn in 2026 and is expected to reach USD 8.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.13 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.60% | 2033 Value Projection: | USD 8.02 Bn |
Point of care (POC) diagnostics refers to medical diagnostic testing performed outside a laboratory, near or at the site of patient care. Traditionally, most diagnostic tests were conducted in centralized laboratories. However, POC diagnostics helps deliver faster results, enable quick clinical decisions, and provide treatment immediately without transferring samples to distant labs. Technological advancements have enabled the development of portable and easy-to-use devices suitable for near-patient settings like doctor's offices, emergency rooms, pharmacies, and homes. Rising demand for rapid testing and decentralized healthcare, increasing incidence of infectious diseases and growing elderly population susceptible to chronic conditions can drive the global point of care diagnostics market growth.
Market Dynamics
Global point of care diagnostics market growth is driven by factors like growing demand for rapid, convenient and real-time test results, increasing prevalence of chronic and infectious diseases, rising geriatric population worldwide, technological advancements leading to development of user-friendly and portable POC devices. However, lack of infrastructure and skilled professionals in developing nations, high cost of advanced POC devices, and unreliable test results associated with some devices can hamper the market growth. Moreover, untapped opportunities in emerging markets, integration of advanced technologies like AI and IoT with POC devices, and growing applications of POC testing in home healthcare can offer significant opportunities for the market players.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global point of care diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Becton, Dickinson and Company, Johnson & Johnson, Danaher Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global point of care diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global point of care diagnostics market
Market Segmentation
- By Technology Insights (Revenue, USD Bn, 2026 - 2033)
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- Biosensors
- By Application Insights (Revenue, USD Bn, 2026 - 2033)
- Cardio Metabolic Testing
- Infectious Disease Testing
- Nephrology Testing
- Drugs of Abuse (DoA) Testing
- Blood Glucose Testing
- Pregnancy Testing
- Cancer Biomarker Testing
- Others
- By End User Insights (Revenue, USD Bn, 2026 - 2033)
- Hospitals
- Diagnostic Laboratories
- Home-Care Settings
- Others
- By Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Siemens Healthineers AG
- Becton, Dickinson and Company
- Qiagen Inc.
- Johnson & Johnson Services, Inc.
- Danaher Corporation (Beckman Coulter Inc.)
- Instrumentation Laboratory
- Nova Biomedical Corporation
- Biomeriux SA
- GE Healthcare
- Philips Healthcare
- Quest Diagnostics
- Fujifilm Medical
- Thermo Fisher Scientific
- Hologic
- Canon
- IDEXX Laboratories
- Sysmex
- QuidelOrtho
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Point of Care Diagnostics Market, By Technology
- Global Point of Care Diagnostics Market, By Application
- Global Point of Care Diagnostics Market, By End User
- Global Point of Care Diagnostics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Point of Care Diagnostics Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Lateral Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Agglutination Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Flow-Through
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Solid Phase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biosensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Point of Care Diagnostics Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cardio Metabolic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nephrology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Drugs of Abuse (DoA) Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Blood Glucose Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pregnancy Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cancer Biomarker Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Point of Care Diagnostics Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Point of Care Diagnostics Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation (Beckman Coulter Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Instrumentation Laboratory
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nova Biomedical Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biomeriux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Canon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IDEXX Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sysmex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QuidelOrtho
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
